Table 1 Drugs with low desmoid cell proliferation rate, their therapeutic groups and reference points.
From: Efficacy of auranofin as an inhibitor of desmoid progression
Relative absorption | Chemical name | Therapeutic group | Reference |
|---|---|---|---|
0.313 | Terfenadine | Anti-histaminic | Discontinued due to cardiotoxicity |
0.324 | Auranofin | Anti-rheumatic | PMDA approved drug for rheumatoid arthritis |
0.329 | Alexidine dihydrochloride | Anti-biotic | Cleaning solution for contact lenses |
0.344 | Thimerosal | Anti-septic | Organic mercury compounds |
0.346 | Suloctidil | Vasodilator | Not available in Japan |
0.42 | Cantharidin | Dermal irritant | External medicine |
0.442 | Beta-Escin | Anti-inflammatory | Reagent |
0.47 | Ebselen | Anti-inflammatory | External medicine |
0.501 | Thonzonium bromide | Monocationic detergen | Ear drops |
0.511 | Mefloquine hydrochloride | Anti-malarial | PMDA approved drug for antiprotozoal |
